Evidence map›Paper›PMID 26365340›Full record

ArticleAmerican journal of human genetics2015

Truncating Mutations of MAGEL2, a Gene within the Prader-Willi Locus, Are Responsible for Severe Arthrogryposis.

Dan Mejlachowicz, Flora Nolent, Jérome Maluenda, Hanitra Ranjatoelina-Randrianaivo, Fabienne Giuliano, Ivo Gut, Damien Sternberg, Annie Laquerrière, Judith Melki

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in American journal of human genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. MAGEL2 (patho-)physiology and Schaaf-Yang syndrome.Developmental medicine and child neurology · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Dan MejlachowiczUMR-1169, INSERM and University of Paris South, Le Kremlin Bicêtre, 94276, France.
Flora NolentUMR-1169, INSERM and University of Paris South, Le Kremlin Bicêtre, 94276, France.
Jérome MaluendaUMR-1169, INSERM and University of Paris South, Le Kremlin Bicêtre, 94276, France.
Hanitra Ranjatoelina-RandrianaivoMedical Genetic Unit, South University Hospital, St Pierre-La Réunion, 97448, France.
Fabienne GiulianoReference Center of Developmental Anomalies and Malformations, University Hospital of Nice, Nice, 06000, France.
Ivo GutCentro Nacional de Análisis Genómico, Barcelona, 080028, Spain.
Damien SternbergService de Biochimie Métabolique and UMR 1127-7225, Hôpitaux Universitaires Pitié-Salpêtrière, Paris, 75651, France.
Annie LaquerrièrePathology Laboratory and NeoVasc Region-INSERM Team ERI28, Institute of Research for Innovation in Biomedicine, University of Rouen, Rouen, 76031, France.
Judith MelkiUMR-1169, INSERM and University of Paris South, Le Kremlin Bicêtre, 94276, France. Electronic address: judith.melki@inserm.fr.
Inserm · FRCentro Nacional de Análisis Genómico · ESSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arthrogryposis multiplex congenita (AMC) is characterized by the presence of multiple joint contractures resulting from reduced or absent fetal movement. Here, we report two unrelated families affected by lethal AMC. By genetic mapping and whole-exome sequencing in a multiplex family, a heterozygous truncating MAGEL2 mutation leading to frameshift and a premature stop codon (c.1996delC, p.Gln666Serfs∗36) and inherited from the father was identified in the probands. In another family, a distinct heterozygous truncating mutation leading to frameshift (c.2118delT, p.Leu708Trpfs∗7) and occurring de novo on the paternal allele of MAGEL2 was identified in the affected individual. In both families, RNA analysis identified the mutated paternal MAGEL2 transcripts only in affected individuals. MAGEL2 is one of the paternally expressed genes within the Prader-Willi syndrome (PWS) locus. PWS is associated with, to varying extents, reduced fetal mobility, severe infantile hypotonia, childhood-onset obesity, hypogonadism, and intellectual disability. MAGEL2 mutations have been recently reported in affected individuals with features resembling PWS and called Schaaf-Yang syndrome. Here, we show that paternal MAGEL2 mutations are also responsible for lethal AMC, recapitulating the clinical spectrum of PWS and suggesting that MAGEL2 is a PWS-determining gene.

Indexed as

ArthrogryposisCase-Control StudiesChromosomes, Human, Pair 15FemaleFetusGene Expression ProfilingGenomic ImprintingHumansInfant, NewbornIntracellular Signaling Peptides and ProteinsIntrinsically Disordered ProteinsMaleMutationPedigreePrader-Willi SyndromeProteinsIntracellular Signaling Peptides and ProteinsIntrinsically Disordered ProteinsMAGEL2 protein, humanProteins

Identifiers

PMID26365340
PMCPMC4596890
OpenAlexW1665554318

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.